Michael Brent

[Donald K. Johnson Eye Institute @DKJEI_UHN]

Yesterday, we celebrated the opening of our new Clinical Research Unit @DKJEI_UHN.

The CRU will bring together clinicians and researchers, to translate basic science discoveries into clinical applications, to help preserve and restore vision.

[Justin Presseau @JPresseau]

Eye screening for diabetic retinopathy is important for avoiding sight-threatening complications but there are +++ barriers. Our co-development of a linguistically/culturally tailored theory-informed intervention to support access & screening: https://t.co/8NzNpmsjxi @TOH_CIR

[Michael Brent @michaelbrentmd]

@CanJOphth Excellent review!

[Brad Wouters 🇨🇦 @bradwouters]

Preserving sight for people with diabetes /via @globeandmail featuring research from @DrValRac @TGHRI_UHN @trogersresearch @UHN
https://t.co/iVV3paIE0N

[Val Rac @DrValRac]

Ms. Debbie Sissmore and her husband, Mr. Malcolm Sissmore have been guiding our provincial and national diabetic retinopathy screening initiatives and evaluations since their conceptualization. Their continuous engagement and input are crucial.

[Doug Earle @EarleDoug]

Retrospective study compares AI, teleophthalmology diagnosis for diabetic retinopathy https://t.co/ddPoZB7neZ via @modernretina

[Doug Earle @EarleDoug]

J&J buys an early-stage gene therapy for the eye — the only known program for an under-the-radar biotech - https://t.co/JHFR85MVk9

[Doug Earle @EarleDoug]

Prevalence and predictors for being unscreened for diabetic retinopathy: a population-based study over a decade https://t.co/lMPzOluRLm
@TinaFelfeli @michaelbrentmd @FB_Canada

[Doug Earle @EarleDoug]

New study seeks to expand eye screenings for rural diabetic patients throughout the United States
https://t.co/XXkM462Qdz

[Diabetes Action Can. @_DiabetesAction]

New publication from @TinaFelfeli and DAC’s @michaelbrentmd looks at accuracy of teleretinal screening for diabetic retinopathy. https://t.co/NDn6pQ7xHG

[Doug Earle @EarleDoug]

We need public coverage of Luxturna now ... Adam is losing 10,000 photoreceptors a day while government dithers - send an email to your Premier now https://t.co/WklbpoHYwp @FB_Canada
https://t.co/pMwL9VM2vL

[Michael Brent @michaelbrentmd]

So Cool!

[Steve Stewart-Williams @SteveStuWill]

The amazing camouflage of the great grey owl. Over the course of its evolution, any gene that happened to make the owl a little less visible had a greater chance of being passed on. The gradual accumulation of such genes led to the near-perfect camouflage we see today.

[Tina Felfeli, MD PhD @TinaFelfeli]

Our meta-analysis in collaboration with @_DiabetesAction validates that teleretinal screening is highly accurate for diagnosis of #DiabeticRetinopathy, while evidence for diagnosis of #AMD is more limited.

@CANeyeMDs @KBI_UHN @FB_Canada @ihpmeuoft

https://t.co/IwklmDu3Wj

[Marko Popovic @PopovicMM]

Our new meta-analysis in @RetinaJournal of over 1 million patients shows no association between the use of statins and the incidence of age-related macular degeneration: https://t.co/amvzzKHG7j

Thank you to my coauthors on this important work.

#Ophthalmology #retina

[Michael Brent @michaelbrentmd]

@powconrad Happy Birthday to your dad!

[Doug Earle @EarleDoug]

Novartis inks $800M upfront buyout of Gyroscope to continue eye disease gene therapy M&A spree
key is a gene therapy, GT005, that is in phase 2 development as a treatment for geographic atrophy
https://t.co/xtkOT8EThp

[Doug Earle @EarleDoug]

Teleretinal screening for #DiabeticRetinopathy provides effective disease monitoring https://t.co/9e1xlHNgaG via @OTEurope

@FB_Canada is supporting a major screening #diabetes @_DiabetesAction called Project Open - thanks to support from @TD_Canada

[Doug Earle @EarleDoug]

Novartis announces positive results from year two of the Phase III trial of Beovu in diabetic macular edema https://t.co/fXqNrRFK16 via @OphthTimes

[Fighting Blindness Canada @FB_Canada]

BREAKING NEWS!
Canadian Provincial governments have agreed to move forward to negotiate access to Luxturna! Visit https://t.co/MXt0mPY5hj to send an email to your Premier & your Health Minister with a new message - to expedite negotiating access to Luxturna NOW. #ApproveLuxturna